So you have a patient who has failed a PPI for GERD. Now what? GERD can be a challenging disease with really bothersome symptoms for patients. I’m going to discuss the options that I’ve seen used in practice with once-daily PPI failure in GERD. Before...
Loperamide (Imodium) is an antidiarrheal and antimotility agent used to help manage and treat traveler’s diarrhea, irritable bowel syndrome associated with chronic diarrhea, acute nonspecific diarrhea in patients two years and older, and reduce ileostomy output....
Gastroparesis is a condition in which stomach motility is reduced due to nerve injury and/or muscle dysfunction. Due to this reduced motility, the stomach is unable to properly empty itself, leading to symptoms that may include nausea, vomiting, bloating, heartburn,...
In part 2 of our series on CDAI basics in Crohn’s disease, I wanted to cover moderate to severe Crohn’s disease and how treatment may look a little different. As a quick refresher, CDAI stands for Crohn’s Disease Activity Index and as you can imagine...
The Crohn’s Disease Activity Index (CDAI) is just what it sounds like. It is an assessment tool designed to determine the severity of Crohn’s disease. Wait, isn’t this a diagnostic tool intended for diagnosticians? As a pharmacist, why do I need to...
Proton Pump Inhibitors (PPIs) are a well-known staple in the management of upper GI bleeds (UGIB). Recently, there was a question regarding the efficacy and appropriateness of PPI use in lower GI bleeds (LGIB). First, let’s evaluate some common characteristics used to...
